Page last updated: 2024-12-06

oxindanac

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

oxindanac: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68879
CHEMBL ID2107505
SCHEMBL ID379375
MeSH IDM0118758

Synonyms (39)

Synonym
5-benzoyl-6-hydroxyindane-1-carboxylic acid
oxindanac
5-benzoyl-6-hydroxy-2,3-dihydro-1h-indene-1-carboxylic acid
68548-99-2
(+-)-5-benzoyl-6-hydroxy-1-indancarboxylic acid
oxindanaco
oxindanacum
oxindanac [inn]
zy400r3bnt ,
unii-zy400r3bnt
oxindanacum [latin]
oxindanaco [spanish]
oxindazac
cgp-6258
CHEMBL2107505
99910-69-7
5-benzoyl-6-methoxy-1-indancarboxylic acid
1h-indene-1-carboxylic acid, 5-benzoyl-2,3-dihydro-6-hydroxy-
oxindanac [mart.]
(+/-)-5-benzoyl-6-hydroxy-1-indancarboxylic acid
XMTKXTUIUKKGIL-UHFFFAOYSA-N
5-benzoyl-6-hydroxy-indane-1-carboxylic acid
SCHEMBL379375
unii-ps75787kji
unii-0k7u57mh88
oxindanac, (+)-
(-)-5-benzoyl-2,3-dihydro-6-hydroxy-1h-indene-1-carboxylic acid
1h-indene-1-carboxylic acid, 5-benzoyl-2,3-dihydro-6-hydroxy-, (+)-
oxindanac, (-)-
PS75787KJI ,
1h-indene-1-carboxylic acid, 5-benzoyl-2,3-dihydro-6-hydroxy-, (-)-
99910-67-5
0K7U57MH88 ,
99910-68-6
(+)-5-benzoyl-2,3-dihydro-6-hydroxy-1h-indene-1-carboxylic acid
TQP1434
Q27295940
5-benzoyl-6-hydroxy-2,3-dihydro-1h-indene-1-carboxylicacid
DTXSID60867671

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Plasma pharmacokinetic data were fitted to either two or three compartment open models."( Correlation between the pharmacokinetics of oxindanac and inhibition of serum thromboxane B2 in calves.
King, JN, 1994
)
0.55

Bioavailability

ExcerptReferenceRelevance
" Bioavailability was incomplete (F = 66."( High performance liquid chromatography and pharmacokinetics of the non-steroidal anti-inflammatory drug oxindanac in calves.
Hauffe, SA; King, JN; Le Goff, C; Mauron, C; Voirol, MJ, 1994
)
0.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (64.29)18.7374
1990's5 (35.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (26.67%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]